DK1149092T3 - 4- og 5-alkynyloxindoler og 4- og 5-alkenyloxindoler - Google Patents

4- og 5-alkynyloxindoler og 4- og 5-alkenyloxindoler

Info

Publication number
DK1149092T3
DK1149092T3 DK99957341T DK99957341T DK1149092T3 DK 1149092 T3 DK1149092 T3 DK 1149092T3 DK 99957341 T DK99957341 T DK 99957341T DK 99957341 T DK99957341 T DK 99957341T DK 1149092 T3 DK1149092 T3 DK 1149092T3
Authority
DK
Denmark
Prior art keywords
alkynyloxindoles
alkenyloxindoles
protein kinases
inhibit
useful
Prior art date
Application number
DK99957341T
Other languages
Danish (da)
English (en)
Inventor
Kin-Chun Luk
Paige E Mahaney
Steven Gregory Mischke
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1149092T3 publication Critical patent/DK1149092T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
DK99957341T 1998-12-17 1999-12-07 4- og 5-alkynyloxindoler og 4- og 5-alkenyloxindoler DK1149092T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11258998P 1998-12-17 1998-12-17
US14148299P 1999-06-29 1999-06-29
PCT/EP1999/009578 WO2000035906A2 (en) 1998-12-17 1999-12-07 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles

Publications (1)

Publication Number Publication Date
DK1149092T3 true DK1149092T3 (da) 2004-02-23

Family

ID=26810125

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99957341T DK1149092T3 (da) 1998-12-17 1999-12-07 4- og 5-alkynyloxindoler og 4- og 5-alkenyloxindoler

Country Status (14)

Country Link
EP (1) EP1149092B1 (pt)
JP (1) JP2002532490A (pt)
KR (1) KR20010087421A (pt)
CN (1) CN1147486C (pt)
AT (1) ATE253062T1 (pt)
AU (1) AU771599B2 (pt)
BR (1) BR9916272A (pt)
CA (1) CA2354510A1 (pt)
DE (1) DE69912479T2 (pt)
DK (1) DK1149092T3 (pt)
ES (1) ES2209527T3 (pt)
PT (1) PT1149092E (pt)
TR (1) TR200101747T2 (pt)
WO (1) WO2000035906A2 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
MY128450A (en) 2000-05-24 2007-02-28 Upjohn Co 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
EP1294688A2 (en) 2000-06-02 2003-03-26 Sugen, Inc. Indolinone derivatives as protein kinase/phosphatase inhibitors
WO2002002551A1 (en) * 2000-06-30 2002-01-10 Sugen, Inc. 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
WO2002083648A1 (en) 2001-04-16 2002-10-24 Eisai Co., Ltd. Novel 1h-indazole compound
AR035971A1 (es) * 2001-05-16 2004-07-28 Cephalon Inc Metodos para el tratamiento y la prevencion del dolor
WO2002096361A2 (en) 2001-05-30 2002-12-05 Sugen, Inc. 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
DE60230625D1 (de) 2001-07-23 2009-02-12 Serono Lab Arylsulfonamidderivate als hemmer c-jun-terminaler kinasen (jnk)
JP4164028B2 (ja) 2001-10-12 2008-10-08 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アルキンマトリックスメタロプロテイナーゼ阻害剤
US6962922B2 (en) 2001-10-12 2005-11-08 Warner-Lambert Company Llc Alkynylated quinazoline compounds
JP4388376B2 (ja) * 2002-02-28 2009-12-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規な縮合環インダゾール化合物
US6894057B2 (en) 2002-03-08 2005-05-17 Warner-Lambert Company Oxo-azabicyclic compounds
US6747147B2 (en) 2002-03-08 2004-06-08 Warner-Lambert Company Oxo-azabicyclic compounds
TW200406385A (en) 2002-05-31 2004-05-01 Eisai Co Ltd Pyrazole compound and pharmaceutical composition containing the same
CA2487948A1 (en) 2002-06-14 2003-12-24 Applied Research Systems Ars Holding N.V. Azole methylidene cyanide derivatives and their use as protein kinase modulators
BRPI0415773A (pt) 2003-10-24 2006-12-26 Schering Ag derivados de indolinona e sua aplicação no tratamento de estados de doença tais como cáncer
DE102004012070A1 (de) * 2004-03-12 2005-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
US20060094753A1 (en) 2004-10-29 2006-05-04 Alcon, Inc. Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
US7803824B2 (en) 2004-10-29 2010-09-28 Alcon, Inc. Use of inhibitors of Jun N-terminal kinases to treat glaucoma
WO2006090698A1 (ja) * 2005-02-22 2006-08-31 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 jnk 억제제
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
CN1939922B (zh) * 2005-09-27 2010-10-13 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的5H-噻吩[3,4-c]吡咯-4,6-二酮衍生物
RU2008112691A (ru) 2005-10-03 2009-10-10 Оно Фармасьютикал Ко., Лтд. (Jp) Азотсодержащее гетероциклическое соединение и его фармацевтическое применение
FR2962729B1 (fr) 2010-07-13 2012-09-21 Arkema France Molecules porteuses de groupes associatifs
FR2962733B1 (fr) 2010-07-13 2012-08-17 Michelin Soc Tech Polymere greffe par des molecules associatives azotees.
US20140205537A1 (en) * 2011-06-24 2014-07-24 Zenobia Therapeutics, Inc. Lrrk2 inhibitors
US11919336B2 (en) 2019-11-27 2024-03-05 Industrial Technology Research Institute Self-powered sensing and transmitting device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501567D0 (en) * 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
GB9507298D0 (en) * 1995-04-07 1995-05-31 Pharmacia Spa Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
GB9610964D0 (en) * 1996-05-24 1996-07-31 Pharmacia & Upjohn Spa Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
EP0929520B1 (en) * 1996-08-23 2005-11-02 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
CA2289102A1 (en) * 1997-05-07 1998-11-12 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity

Also Published As

Publication number Publication date
KR20010087421A (ko) 2001-09-15
AU1507600A (en) 2000-07-03
CN1331689A (zh) 2002-01-16
EP1149092B1 (en) 2003-10-29
CA2354510A1 (en) 2000-06-22
DE69912479D1 (de) 2003-12-04
WO2000035906A2 (en) 2000-06-22
ATE253062T1 (de) 2003-11-15
AU771599B2 (en) 2004-03-25
TR200101747T2 (tr) 2001-11-21
BR9916272A (pt) 2001-09-04
DE69912479T2 (de) 2004-07-22
EP1149092A2 (en) 2001-10-31
WO2000035906A3 (en) 2000-11-09
CN1147486C (zh) 2004-04-28
JP2002532490A (ja) 2002-10-02
ES2209527T3 (es) 2004-06-16
PT1149092E (pt) 2004-03-31

Similar Documents

Publication Publication Date Title
DK1149092T3 (da) 4- og 5-alkynyloxindoler og 4- og 5-alkenyloxindoler
BR9916223A (pt) 4-ariloxindóis como inibidores de cinases de proteìna jnk
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
UY27972A1 (es) Derivados de hidantoína
MY129409A (en) Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
MX9700557A (es) Dihidrobenzofuranos.
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
BR0010220A (pt) Compostos de pirimidinona
ATE253063T1 (de) 5-ht1f-agonisten
DK0705100T3 (da) Terapeutiske substituerede guanidiner
ATE355284T1 (de) Inhibitoren von serinproteasen
AU2001274220A1 (en) Serine protease inhibitors
BR9916324A (pt) 4,5-pirazinoxindóis como inibidores de proteìna quinase
GB0114185D0 (en) Compounds
DE69915686D1 (de) Amidinoderivate und ihre verwendung als thrombin-inhibitoren
DK1204659T3 (da) Serotonerge benzofuraner
FI955118A (fi) Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit
EA199900534A1 (ru) Имидазопиридазины
BG104292A (en) Methods and compositions for the treatment of rheumatoid arthritis
EP1476149A4 (en) SUBSTITUTED HYDRAZONES AS INHIBITORS OF CYCLOOXYGENASE-2
DE69930844D1 (de) Inhibitoren von mycobakterien
DE60224805D1 (de) 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine un
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
BR9407232A (pt) Compostos de tiocarbamoíla